Calendar IGC Pharma, Inc.

Equities

IGC

US45408X3089

Market Closed - Nyse 21:00:00 01/05/2024 BST 5-day change 1st Jan Change
0.508 USD -6.27% Intraday chart for IGC Pharma, Inc. +15.72% +81.36%

Chart calendar IGC Pharma, Inc.

17381f33a7e616bad28afbe.1mBGb-JbxZLUK0WF4bfPUCNPSaY-egL4hVGYvGNAO_0.mAEEQs9sr8aechrGqvj4AFsaMJZzL2awyBXRyzk3QriyWD4ZkQqd_eBlAA~973e0be175593d84717997c7ed5dd15c

Upcoming events on IGC Pharma, Inc.

19/06/2024 Q4 2024 Earnings Release (Projected)
06/08/2024 Q1 2025 Earnings Release (Projected)
05/11/2024 Q2 2025 Earnings Release (Projected)
11/02/2025 Q3 2025 Earnings Release (Projected)

Past events on IGC Pharma, Inc.

20/03/2024 16:30 Benzinga Healthcare Summit
17/02/2024 00:05 Q3 2024 Earnings Release
08/01/2024 22:00 Biotech Showcase
13/11/2023 13:00 Q2 2024 Earnings Release
18/08/2023 16:00 Annual General Meeting
14/08/2023 13:30 Q1 2024 Earnings Release
18/07/2023 07:45 Alzheimer Association International Conference - Poster Number: P3-662
18/07/2023 07:45 Alzheimer Association International Conference - Poster Number: P3-660
18/07/2023 07:45 Alzheimer Association International Conference - Poster Number:P3-657
18/07/2023 07:45 Alzheimer Association International Conference - Poster Number:P3-663
18/07/2023 07:45 Alzheimer Association International Conference - Poster Number:P3-648
17/07/2023 07:45 Alzheimer’s Association International Conference - Poster Number:P2-694
12/07/2023 13:44 Q4 2023 Earnings Release
06/06/2023 23:00 LD Micro Invitational Conference
27/04/2023 00:30 Planet MicroCap Showcase
29/03/2023 16:30 Investor Summit
15/02/2023 00:41 Q3 2023 Earnings Release
10/02/2023 17:30 Radius Research Investor Conference
05/12/2022 16:20 RHK Capital Disruptive Growth Conference
02/12/2022 16:00 Business Update Call

Annual results

Fiscal PeriodMarch 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00



1,24

EBITDA
Released
Forecast
Spread
0,00



0,00

EBIT
Million USD
Released
Forecast
Spread
0,00



-10,3

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00



-12,8

Net income
Million USD
Released
Forecast
Spread
-11,5



-12,8

EPS
USD
Released
Forecast
Spread
-0,22



-0,22

Announcement Date07/07/23-

Quarterly results

Fiscal PeriodMarch 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales
Million USD
Released
Forecast
Spread
0,20
0,45
-54.46%

0,19


0,62


0,33


0,23


0,22

EBIT
Million USD
Released
Forecast
Spread
-3,00
-2,43
-23.32%

-2,68


-2,43


-2,60


-2,66


-2,67

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-5,59
-2,44
-129.43%

-2,69


-2,47


-2,65


-2,70


-2,71

Net income
Million USD
Released
Forecast
Spread
-5,59
-2,44
-129.43%

-2,69


-2,47


-2,65


-2,70


-2,71

EPS
USD
Released
Forecast
Spread
-0,09
-0,04
-125%

-0,04


-0,04


-0,04


-0,04


-0,04

Announcement Date14/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. IGC Stock
  4. Calendar IGC Pharma, Inc.